Klippel-Trenaunay Syndrome Treatment Market Comprehensive Study of Current Trends and Forecast 2018-2023
Market Highlights
Klippel-trenaunay syndrome (KTS) is a rare congenital
vascular disorder in which a limb may be affected by port wine stains, varicose
veins, and bone and soft tissue growth. The limb may be larger, longer or
warmer than normal. The symptoms and severity of KTS differ from patient to
patient. Symptoms include bleeding from the affected limb, a skin infection,
blood in the urine, or rectal/vaginal bleeding. The person can experience pain
in the limb, blood clots, anemia, and seizures.
Factors such as technological advancements,
increasing awareness, lifestyle changes are the major driving factors for the
growth of the market. The high cost of surgical procedures and risks involved
in procedures are likely to affect the Klippel-trenaunay syndrome treatment
market negatively.
Segmentation
The global Klippel-trenaunay syndrome treatment
market has been segmented on the basis of type and end users. On the basis of
type, the market has been classified as medication, compression therapy,
physical therapy, orthopedic devices, epiphysiodesis, embolization, laser
therapy, endovenous thermal ablation, sclerotherapy, surgery. On the basis of
end users, the market has been classified as hospitals, clinics, ambulatory
care, home care, and others.
Regional Analysis
The Americas is projected to lead the
Klippel-trenaunay syndrome treatment market in the forecast period. Increasing
healthcare awareness, advancement in technology, medical tourism are some other
factors that boost the growth of the market. According to Scitable by nature,
every year, an estimated 7.9 million infants are born with serious birth
defects. Though some congenital defects can be controlled and treated, an
estimated 3.2 million of these children are disabled for life. Moreover, birth
defects are the leading cause of infant mortality in the US.
The European market is expected to hold the second
largest market share. According to the statistics, of the British Lung
Foundation in the year 2014, around 10,000 people in the United Kingdom are
newly diagnosed with a respiratory disease every week. According to the
statistics, of Eurordis in partnership with Orphanet, the number of prevalence
cases of Klippel-trenaunay syndrome was 1000 /100 000 in 2014.
Asia-Pacific is projected to be the fastest growing
region for the global Klippel-trenaunay syndrome treatment market in 2018. The
market is expected to witness growth owing to the rising patient population,
changing lifestyle, and growing elderly population.
The Middle East and Africa accounts for the least
share due to stringent government policies and low per capita income.
Access the full report @
Key Players
Some of the key players in the global Klippel-trenaunay
syndrome treatment market are Stryker Corp., DePuy Synthes, Zimmer Biomet,
Smith & Nephew, Medtronic Spinal, DJO Global, Integra Lifesciences,
NuVasive Inc., Globus Medical, Wright Medical, Pfizer Inc., Biocon India Ltd.,
and Wyeth Limited.
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment